Article Information
History
- February 2, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- JD Warda,*,
- C Cornabyb,
- T Katoc,
- RC Gilmorec,
- D Bunchd,
- MB Millera,e,
- RC Boucherc,
- JL Schmitza,b,
- FA Askina and
- LR Scangaa,*
- aUniversity of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina, USA
- bImmunology, Histocompatibility and Immunogenetics Laboratories/McLendon Clinical Laboratories UNC Hospitals, Chapel Hill, North Carolina, USA
- cUniversity of North Carolina School of Medicine, Marisco Lung Institute/UNC Cystic Fibrosis Center, Chapel Hill, North Carolina, USA
- dUniversity of North Carolina School of Medicine, Department of Medicine, Division of Nephrology and Hypertension, Chapel Hill, North Carolina, USA
- eClinical Microbiology and Molecular Microbiology Laboratories, University of North Carolina Health Care, Chapel Hill, North Carolina, USA
- ↵*Corresponding authors: Jeremy D. Ward
(Address: Department of Pathology and Laboratory Medicine, Campus Box #7525, Brinkhous-Bullitt Building, Chapel Hill, NC 27599-7525, United States; Telephone: 984-974-1476; Email: jeremy.ward{at}unchealth.unc.edu, Lori R. Scanga
(Address: Department of Surgical Pathology, Women’s and Children’s Hospitals, 3rd Floor, Room 30149, 101 Manning Drive, Chapel Hill, NC 27514; Telephone: 984-974-9142; Email: lori.scanga{at}unchealth.unc.edu)
Posted February 02, 2022.
The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies
